ENDEFR
Home › United States › ASCENT PHARMACEUTICALS INC.

ASCENT PHARMACEUTICALS INC.

Business Corporation · ISLIP, United States · LEI 254900AO9Q3BS3IMME22
LEI active

Summary

ASCENT PHARMACEUTICALS INC. is registered in the United States. Its legal form is Business Corporation. According to GLEIF, its ultimate parent is HETERO LABS LIMITED (India), which is also its direct parent. That group has 5 subsidiaries with LEIs in 2 countries, 1 of them in the United States. The LEI was first issued on 7 Jan 2020 and the record was last updated on 19 Jan 2026; the next renewal is due by 17 Feb 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2019, more than 24 months before this data release. The group may have changed since.

Company details

Legal formBusiness Corporation
Register · Register website
Registration number4136894
Registration authorityCorporation and Business Entity Database (Division of Corporations, State Records and UCC, Department of State)
JurisdictionUnited States (US-NY)
Registered address400 S TECHNOLOGY DRIVE, CENTRAL ISLIP, 11722 ISLIP, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)31 Aug 2011
LEI254900AO9Q3BS3IMME22
LEI statusactive
LEI first issued7 Jan 2020
LEI record last updated19 Jan 2026
Next LEI renewal17 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

HETERO LABS LIMITED India ultimate parent
ASCENT PHARMACEUTICALS INC. this entity
View the whole group: 5 subsidiaries in 2 countries

Relationship to the parent

Direct parentUltimate parent
ParentHETERO LABS LIMITEDHETERO LABS LIMITED
Accounting period1 Apr 2016 to 31 Dec 20191 Apr 2016 to 31 Dec 2019
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Consolidation percentage reported to GLEIF51.00%51.00%
Relationship start1 Apr 20161 Apr 2016
Recorded at GLEIF since7 Jan 20207 Jan 2020
Last updated19 Jan 202619 Jan 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (4)

ISINs mapped to this LEI (1)

US04362W2026

1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.